Adverse effects are generally uncommon; however, there have been reports of the following:

- Cardiovascular: edema, hypertension, thrombophlebitis, retinal thrombosis.

- Central Nervous System: headache, depression, pain, dizziness, anxiety, migraine, nipple pain

- Respiratory: nasopharyngitis, flu-like symptoms, sinusitis, upper respiratory tract infection, headache, bronchitis, sinus congestion, pharyngitis, asthma exacerbation, cough

- Dermatologic: skin rash, pruritus, erythema multiforme, erythema nodosum, urticaria

- Skeletal: arthralgia, weakness, back and neck pain, limb pain, myalgia, leg cramps

- Endocrine: weight gain or loss, hot flash, libido changes, hirsutism, menstrual changes, porphyria exacerbation, fluid retention, hypocalcemia, elevated triglycerides, galactorrhea

- Gastrointestinal: Abdominal pain, constipation, heartburn, flatulence, bloating, nausea, vomiting, diarrhea, pancreatitis, gastroenteritis, carbohydrate intolerance

- Hypersensitivity: anaphylaxis, angioedema, hypersensitivity reactions

- Hepatic: Hepatic hemangioma exacerbation, jaundice

- Ophthalmic: conjunctivitis, steepening of the cornea, contact lens intolerance

- Infections: fungal and other infections

- Otic: Otitis media

**The United States Food and Drug Administration (FDA) Boxed Warnings**

- Women who take estrogen plus progestin therapy are at increased risk for breast cancer.

- Women with increased exposure to estrogen are at risk for endometrial cancer. Estrogen stimulates endometrial growth, which results in endometrial hyperplasia, which could result in endometrial cancer.

- Other risk factors to increased exposure to estrogen HRT are cerebrovascular events, coronary artery disease, and venous thromboembolism.